For Immediate Release
RANCHO SANTA FE - Innolytics, a privately held San Diego company, announced Monday that the US Patent and Trademark Office (USPTO) has issued a patent for their contraceptive technology. The new patent was granted to Dr. Alexander MacDonald, founder of Pharma Science, Inc. and co-founder of Innolytics, LLC. The company stated that the patent effectively provides broad exclusivity for the OvoControl® brand of products. When fed to targeted birds, OvoControl (nicarbazin) prevents fertilization of the eggs. Earlier last year, Innolytics announced a contraceptive development program in mammals, financed in part through a Gates Foundation grant. "This patent is a milestone achievement and represents the progress we have made in the field of wildlife contraception," said MacDonald. "There is a demand for safe and effective contraception of wildlife by communities and businesses. We are developing new products to meet this requirement". Established in 2003, Innolytics, LLC is a privately held company that focuses on developing humane population management technology for wildlife. For further information, see the company website at ovocontrol.com.